EcoDrugPlus

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSSARG00000008518
Gene Symbol: CYP26A1
1 External references
207 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSSARG00000012616
Gene Symbol: DGAT1
1 External references
260 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSSARG00000004072
Gene Symbol: DHODH
1 External references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSSARG00000010936
Gene Symbol: DPYD
1 External references
220 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSSARG00000001012
Gene Symbol: DRD3
1 External references
206 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSSARG00000003968
Gene Symbol: ENPP2
1 External references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSSARG00000003271
Gene Symbol: EGLN3
3 External references
206 Possible Orthologues:

Elastase, Neutrophil Expressed

Ensembl ID : ENSSARG00000012992
Gene Symbol: ELANE
1 External references
102 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSSARG00000006244
Gene Symbol: EDNRA
1 External references
265 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSSARG00000004904
Gene Symbol: EDNRB
1 External references
264 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSSARG00000000739
Gene Symbol: EGFR
1 External references
285 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSSARG00000007165
Gene Symbol: ERBB3
1 External references
282 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).